List of Tables
Table 1. Global Idiopathic Gastroparesis Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Prokinetic Agents
Table 3. Key Players of Antiemetic Agents
Table 4. Key Players of Others
Table 5. Global Idiopathic Gastroparesis Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Idiopathic Gastroparesis Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Idiopathic Gastroparesis Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Idiopathic Gastroparesis Drugs Market Share by Region (2019-2024)
Table 9. Global Idiopathic Gastroparesis Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Idiopathic Gastroparesis Drugs Market Share by Region (2025-2030)
Table 11. Idiopathic Gastroparesis Drugs Market Trends
Table 12. Idiopathic Gastroparesis Drugs Market Drivers
Table 13. Idiopathic Gastroparesis Drugs Market Challenges
Table 14. Idiopathic Gastroparesis Drugs Market Restraints
Table 15. Global Idiopathic Gastroparesis Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Idiopathic Gastroparesis Drugs Market Share by Players (2019-2024)
Table 17. Global Top Idiopathic Gastroparesis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Gastroparesis Drugs as of 2023)
Table 18. Ranking of Global Top Idiopathic Gastroparesis Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Idiopathic Gastroparesis Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Idiopathic Gastroparesis Drugs Product Solution and Service
Table 22. Date of Enter into Idiopathic Gastroparesis Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Idiopathic Gastroparesis Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Idiopathic Gastroparesis Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Idiopathic Gastroparesis Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Idiopathic Gastroparesis Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Idiopathic Gastroparesis Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Idiopathic Gastroparesis Drugs Revenue Market Share by Application (2019-2024)
Table 30. Global Idiopathic Gastroparesis Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Idiopathic Gastroparesis Drugs Revenue Market Share by Application (2025-2030)
Table 32. North America Idiopathic Gastroparesis Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Idiopathic Gastroparesis Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Idiopathic Gastroparesis Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Idiopathic Gastroparesis Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Idiopathic Gastroparesis Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Idiopathic Gastroparesis Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Idiopathic Gastroparesis Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Idiopathic Gastroparesis Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Idiopathic Gastroparesis Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Idiopathic Gastroparesis Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Idiopathic Gastroparesis Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Idiopathic Gastroparesis Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Idiopathic Gastroparesis Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Idiopathic Gastroparesis Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Idiopathic Gastroparesis Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Sumitomo Company Detail
Table 48. Sumitomo Business Overview
Table 49. Sumitomo Idiopathic Gastroparesis Drugs Product
Table 50. Sumitomo Revenue in Idiopathic Gastroparesis Drugs Business (2019-2024) & (US$ Million)
Table 51. Sumitomo Recent Development
Table 52. Cadila Pharmaceuticals Company Detail
Table 53. Cadila Pharmaceuticals Business Overview
Table 54. Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Product
Table 55. Cadila Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2019-2024) & (US$ Million)
Table 56. Cadila Pharmaceuticals Recent Development
Table 57. Sanofi Company Detail
Table 58. Sanofi Business Overview
Table 59. Sanofi Idiopathic Gastroparesis Drugs Product
Table 60. Sanofi Revenue in Idiopathic Gastroparesis Drugs Business (2019-2024) & (US$ Million)
Table 61. Sanofi Recent Development
Table 62. Teva Company Detail
Table 63. Teva Business Overview
Table 64. Teva Idiopathic Gastroparesis Drugs Product
Table 65. Teva Revenue in Idiopathic Gastroparesis Drugs Business (2019-2024) & (US$ Million)
Table 66. Teva Recent Development
Table 67. Johnson & Johnson Company Detail
Table 68. Johnson & Johnson Business Overview
Table 69. Johnson & Johnson Idiopathic Gastroparesis Drugs Product
Table 70. Johnson & Johnson Revenue in Idiopathic Gastroparesis Drugs Business (2019-2024) & (US$ Million)
Table 71. Johnson & Johnson Recent Development
Table 72. Pfizer Company Detail
Table 73. Pfizer Business Overview
Table 74. Pfizer Idiopathic Gastroparesis Drugs Product
Table 75. Pfizer Revenue in Idiopathic Gastroparesis Drugs Business (2019-2024) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Kyowa Kirin Pharmaceuticals Company Detail
Table 78. Kyowa Kirin Pharmaceuticals Business Overview
Table 79. Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Product
Table 80. Kyowa Kirin Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2019-2024) & (US$ Million)
Table 81. Kyowa Kirin Pharmaceuticals Recent Development
Table 82. Hanmi Pharm Company Detail
Table 83. Hanmi Pharm Business Overview
Table 84. Hanmi Pharm Idiopathic Gastroparesis Drugs Product
Table 85. Hanmi Pharm Revenue in Idiopathic Gastroparesis Drugs Business (2019-2024) & (US$ Million)
Table 86. Hanmi Pharm Recent Development
Table 87. Ani Pharmaceuticals Company Detail
Table 88. Ani Pharmaceuticals Business Overview
Table 89. Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Product
Table 90. Ani Pharmaceuticals Revenue in Idiopathic Gastroparesis Drugs Business (2019-2024) & (US$ Million)
Table 91. Ani Pharmaceuticals Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Idiopathic Gastroparesis Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Idiopathic Gastroparesis Drugs Market Share by Type: 2023 VS 2030
Figure 3. Prokinetic Agents Features
Figure 4. Antiemetic Agents Features
Figure 5. Others Features
Figure 6. Global Idiopathic Gastroparesis Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Idiopathic Gastroparesis Drugs Market Share by Application: 2023 VS 2030
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Private Clinics Case Studies
Figure 10. Drug Stores Case Studies
Figure 11. E-Commerce Case Studies
Figure 12. Idiopathic Gastroparesis Drugs Report Years Considered
Figure 13. Global Idiopathic Gastroparesis Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Idiopathic Gastroparesis Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Idiopathic Gastroparesis Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Idiopathic Gastroparesis Drugs Market Share by Players in 2023
Figure 17. Global Top Idiopathic Gastroparesis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Gastroparesis Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Idiopathic Gastroparesis Drugs Revenue in 2023
Figure 19. North America Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Idiopathic Gastroparesis Drugs Market Share by Country (2019-2030)
Figure 21. United States Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Idiopathic Gastroparesis Drugs Market Share by Country (2019-2030)
Figure 25. Germany Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Idiopathic Gastroparesis Drugs Market Share by Region (2019-2030)
Figure 33. China Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Idiopathic Gastroparesis Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Idiopathic Gastroparesis Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Idiopathic Gastroparesis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Sumitomo Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2019-2024)
Figure 48. Cadila Pharmaceuticals Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2019-2024)
Figure 49. Sanofi Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2019-2024)
Figure 50. Teva Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2019-2024)
Figure 51. Johnson & Johnson Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2019-2024)
Figure 52. Pfizer Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2019-2024)
Figure 53. Kyowa Kirin Pharmaceuticals Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2019-2024)
Figure 54. Hanmi Pharm Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2019-2024)
Figure 55. Ani Pharmaceuticals Revenue Growth Rate in Idiopathic Gastroparesis Drugs Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed